UNSPSC 51453205: Pyrvinium chloride

This classification denotes an antihelminthic agent with the molecular structure C26H28N3.CL, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, MT7O310S39 chemically known as 6-dimethylamino-2'-(2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)vinyl)-1-methylquinolinium chloride, but more commonly known as pyrvinium chloride, which bears US NIH Compound Identifier 6436141. European Medicines Agency schedules Pyrvinium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10183MIG.

UNSPSC 51453205 Pyrvinium chloride is a Commodity code that in recent state and local procurement activity denotes pharmaceutical and medical supply procurement rather than the single active ingredient its name suggests. State and local governments are using this code to solicit naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic multi-source pharmaceuticals and over-the-counter products, and direct-to-manufacturer prescription fulfillment programs. The issuing bodies span county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health and human services agencies (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance administering member states and Oregon). Work under this code ranges from competitive procurement of specific pharmaceutical products with defined unit quantities and delivery schedules, to exploratory market intelligence gathering through Requests for Information on pharmacy benefit and direct-contracting models.

Geographic activity centers on Florida (Seminole County IFB for naloxone and drug deactivation systems), Texas (HHS RFI on direct-to-manufacturer prescriptions), Minnesota and Oregon through the MMCAP cooperative vehicle for generic pharmaceuticals and OTC products, and municipal procurement in Florida (Tampa Fire Department). Recent representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026; response deadline July 26, 2023) seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries; the City of Tampa's invitation to bid 26P00145 (response deadline March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market for certified Small Local Business Enterprises with an estimated contract value of $700,000; and MMCAP's RFP S1070000015802 (proposals due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products through authorized wholesalers, effective July 1, 2026. The code shows active state and local demand across emergency response, public health, and cooperative purchasing channels.